首页> 外文期刊>International Journal of Nanomedicine >Selective laser sintering fabrication of nano-hydroxyapatite/poly-ε-caprolactone scaffolds for bone tissue engineering applications
【24h】

Selective laser sintering fabrication of nano-hydroxyapatite/poly-ε-caprolactone scaffolds for bone tissue engineering applications

机译:用于骨组织工程应用的纳米羟基磷灰石/聚ε-己内酯支架的选择性激光烧结制造

获取原文
获取外文期刊封面目录资料

摘要

Abstract: The regeneration of functional tissue in osseous defects is a formidable challenge in orthopedic surgery. In the present study, a novel biomimetic composite scaffold, here called nano-hydroxyapatite (HA)/poly-ε-caprolactone (PCL) was fabricated using a selective laser sintering technique. The macrostructure, morphology, and mechanical strength of the scaffolds were characterized. Scanning electronic microscopy (SEM) showed that the nano-HA/PCL scaffolds exhibited predesigned, well-ordered macropores and interconnected micropores. The scaffolds have a range of porosity from 78.54% to 70.31%, and a corresponding compressive strength of 1.38 MPa to 3.17 MPa. Human bone marrow stromal cells were seeded onto the nano-HA/PCL or PCL scaffolds and cultured for 28 days in vitro. As indicated by the level of cell attachment and proliferation, the nano-HA/PCL showed excellent biocompatibility, comparable to that of PCL scaffolds. The hydrophilicity, mineralization, alkaline phosphatase activity, and Alizarin Red S staining indicated that the nano-HA/PCL scaffolds are more bioactive than the PCL scaffolds in vitro. Measurements of recombinant human bone morphogenetic protein-2 (rhBMP-2) release kinetics showed that after nano-HA was added, the material increased the rate of rhBMP-2 release. To investigate the in vivo biocompatibility and osteogenesis of the composite scaffolds, both nano-HA/PCL scaffolds and PCL scaffolds were implanted in rabbit femur defects for 3, 6, and 9 weeks. The wounds were studied radiographically and histologically. The in vivo results showed that both nano-HA/PCL composite scaffolds and PCL scaffolds exhibited good biocompatibility. However, the nano-HA/PCL scaffolds enhanced the efficiency of new bone formation more than PCL scaffolds and fulfilled all the basic requirements of bone tissue engineering scaffolds. Thus, they show large potential for use in orthopedic and reconstructive surgery.
机译:摘要:骨质缺陷中功能组织的再生是整形外科手术中的一种强大挑战。在本研究中,使用选择性激光烧结技术制造了一种新的仿生复合支架,这里称为纳米羟基磷灰石(HA)/聚ε-己内酯(PCL)。表征了支架的宏观结构,形态和机械强度。扫描电子显微镜(SEM)表明纳米-A / PCL支架表现出预先称为良好的宏孔和相互连接的微孔。支架的孔隙率范围为78.54%至70.31%,相应的压缩强度为1.38MPa至3.17MPa。将人的骨髓基质细胞接种在纳米-HA / PCL或PCL支架上,体外培养28天。如细胞连接和增殖水平所示,纳米-HA / PCL显示出优异的生物相容性,与PCL支架的优异的生物相容性相当。亲水性,矿化,碱性磷酸酶活性和茜素红S染色表明,纳米-A / PCL支架比在体外PCL支架更加生物活性。重组人骨形态发生蛋白-2(RHBMP-2)释放动力学的测量表明,在加入纳米HA后,该材料增加了rHBMP-2释放的速率。为了研究复合支架的体内生物相容性和骨质组合,纳米-HA / PCL支架和PCL支架均植入兔股骨缺陷3,6和9周。伤口被射线照射和组织学。体内结果表明,纳米-HA / PCL复合支架和PCL支架均表现出良好的生物相容性。然而,纳米HA / PCL支架高于PCL支架的新骨形成的效率,并满足了骨组织工程支架的所有基本要求。因此,它们显示出在整形外科和重建手术中使用的巨大潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号